{"id":55771,"date":"2022-07-26T11:42:31","date_gmt":"2022-07-26T11:42:31","guid":{"rendered":"https:\/\/www.mymsd.ch\/fr\/?p=55771"},"modified":"2025-11-23T18:27:07","modified_gmt":"2025-11-23T18:27:07","slug":"pd-l1-neg-nsclc-patient-quel-traitemant-est-judicieux","status":"publish","type":"post","link":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/pd-l1-neg-nsclc-patient-quel-traitemant-est-judicieux\/","title":{"rendered":"Patient atteint d\u2019un NSCLC PD-L1 n\u00e9gatif: quel traitement est judicieux?"},"content":{"rendered":"\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"1200\" height=\"429\" src=\"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/11\/Illustration_patients_insight.png\" alt=\"Illustration of a doctor examining a patient with a stethoscope during a check-up\" class=\"wp-image-67430\" srcset=\"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/11\/Illustration_patients_insight.png 1200w, https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/11\/Illustration_patients_insight.png?resize=300,107 300w, https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/11\/Illustration_patients_insight.png?resize=768,275 768w, https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/11\/Illustration_patients_insight.png?resize=1024,366 1024w, https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/11\/Illustration_patients_insight.png?resize=320,114 320w, https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/11\/Illustration_patients_insight.png?resize=120,43 120w\" sizes=\"auto, (max-width: 1200px) 100vw, 1200px\" \/><\/figure>\n\n\n\n<h3 class=\"wp-block-heading has-positive-3-font-size has-border-color has-has-red-border-color-border-color  mhh-mcn-v1-heading mhh-mcn-v1-heading--9ad78e2dbf68a26a73639b8cbb0c6361\"><mark style=\"background-color:#ffffff\" class=\"has-inline-color has-teal-color\">Patient atteint d\u2019un NSCLC PD-L1 n\u00e9gatif: quel traitement est judicieux?<\/mark><\/h3>\n\n\n\n<p class=\"has-border-color has-has-red-border-color-border-color   mhh-mcn-v1-paragraph mhh-mcn-v1-paragraph--0157f4ac4100a370b3290a8fe4f99ed5\">Octobre 2020<br>Un architecte \u00e2g\u00e9 de 60 ans, en retraite anticip\u00e9e, consulte son m\u00e9decin parce qu\u2019il souffre depuis cinq mois de toux s\u00e8che et de douleurs thoraciques. <\/p>\n\n\n\n<p class=\"has-border-color has-has-red-border-color-border-color   mhh-mcn-v1-paragraph mhh-mcn-v1-paragraph--167c9919ef8a4c1eba6a831e5fdf2f6a\">Il a r\u00e9cemment arr\u00eat\u00e9 de fumer \u00e0 cause de ces sympt\u00f4mes, apr\u00e8s avoir consomm\u00e9 40 paquets-ann\u00e9es. Ces trois derniers mois, il a perdu involontairement 4 ou 5&nbsp;kg. Il se plaint de faiblesse g\u00e9n\u00e9rale\/de fatigue depuis un an. Bien qu&rsquo;il soit autonome et puisse encore prendre soin de lui, il se sent fatigu\u00e9 dans ses activit\u00e9s quotidiennes et n\u00e9cessite parfois l&rsquo;aide de son \u00e9pouse.<\/p>\n\n\n\n<p class=\"has-positive-1-font-size has-border-color has-has-red-border-color-border-color   mhh-mcn-v1-paragraph mhh-mcn-v1-paragraph--3fd3eae5702775cbb7309370e7ec79c9\"><strong>Lisez la description de cas compl\u00e8te \u00e0 l\u2019adresse<\/strong><\/p>\n\n\n<div class=\"mhh-mcn-v1-links mhh-mcn-v1-links--2caed1d3efc2058676d335f2e35f1f1d\">\n    <a class=\"mhh-mcn-v1-link mhh-mcn-v1-link--040a8411563f0338a072fb9cca2bba4f mhh-mcn-v1-link--is-variation mhh-mcn-v1-link--button-primary\" href=\"https:\/\/www.mymsd.ch\/de\/wp-content\/uploads\/sites\/13\/2022\/07\/OncoCase-Newsroom_Aug-2022.pdf\" target=\"_self\" aria-label=\"OncoCase Newsroom Aug 2022 pdf link\">\n                    <span class=\"mhh-mcn-v1-link__label\">just-medical.ch<\/span>\n                <\/a><\/div>\n\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\r\n<div class=\"inpsyde-iframe is-responsive has-transparent-background-color\">\r\n    <iframe loading=\"lazy\" height=\"400\" referrerpolicy=\"no-referrer-when-downgrade\" title=\"Ce contenu vous a-t-il \u00e9t\u00e9 pertinent ?\" src=\"https:\/\/go.screver.com\/msd-ch-cx\/newsroom-articles?lang=fr&amp;hideHeader=true\" width=\"100%\"><\/iframe>\r\n<\/div>\n\n\n<nav class=\"wp-block-mconnect-theme-related-content has-background has-light-grey-background-color\">\n\t<div class=\"wp-block-mconnect-theme-related-content__container\">\n\t\t\t\t\t<h3 class=\"wp-block-mconnect-theme-related-content__title\">\n\t\t\t\tContenu connexe\t\t\t<\/h3>\n\t\t\n\t\t\t\t\t<ul class=\"is-grid-layout has-columns has-three-columns has-top-vertical-alignment\">\n\t\t\t\t\n\n\n\n\n\n\t\t\t\t\t\t<li class=\"grid-item\">\n\t\t\t\t\t\t\t<article\n    class=\"content-item content-item-type-post is-display-media-style has-featured-image has-background has-white-background-color has-link post-94771 post type-post status-publish format-standard has-post-thumbnail hentry category-onco-news category-oncology tag-keytruda tag-keytruda-2 tag-nsclc\">\n\t\t\t<div class=\"content-item__media-container\">\n\t\t\t<div class=\"content-media\">\n\t\t\t\t<div class=\"content-media__inner\">\n\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"635\" height=\"475\" src=\"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2024\/04\/Keytruda_banner_box_fr.jpg?w=635&amp;h=475&amp;crop=1\" class=\"content-media__image\" alt=\"\" srcset=\"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2024\/04\/Keytruda_banner_box_fr.jpg 635w, https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2024\/04\/Keytruda_banner_box_fr.jpg?resize=300,224 300w, https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2024\/04\/Keytruda_banner_box_fr.jpg?resize=320,239 320w, https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2024\/04\/Keytruda_banner_box_fr.jpg?resize=120,90 120w, https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2024\/04\/Keytruda_banner_box_fr.jpg?resize=180,135 180w\" sizes=\"auto, (max-width: 635px) 100vw, 635px\" \/>\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\n    \n    <div class=\"content-item__content-container\">\n\t\t<div class=\"content-item__content-body\">\n\t\t\t\t\t\t\t\t\t\t<span\n\t\t\t\t\tclass=\"content-item__primary-tag\"\n\t\t\t\t\ttitle=\"Cet article a \u00e9t\u00e9 \u00e9tiquet\u00e9 comme : NSCLC\"\n\t\t\t\t>\n\t\t\t\t\tNSCLC\t\t\t\t<\/span>\n\t\t\t\t\t\t<header class=\"content-item__header\">\n\t\t\t\t<span\n\t\t\t\t\tclass=\"content-item__content-type content-type  content-type--post\">\n\t\t\t\t\t<span class=\"content-type__icon\">\n                                            <\/span>\n\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t<h2 class=\"content-item__title\" data-enterprise-id=\"currentHeader\">\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/pd-l1-resultats-a-5-ans-issus-de-kn-189-et-kn-407\/\"\n                            class=\"content-item__title-link\"\n                            target=\"_self\"\n                            rel=\"\"\n\t\t\t\t\t\t\t              >\n                            PD-L1 (-): r\u00e9sultats \u00e0 5\u00a0ans issus de KN-189 et KN-407                        <\/a>\n\t\t\t\t\t\t\t\t\t<\/h2>\n\t\t\t\t\t\t\t<\/header>\n\t\t\t\n                                            <div class=\"content-item__content-meta badge-container\">                                                                <div class=\"content-item__dates badge badge--flat badge--dates\">\n                                                        <span class=\"content-item__dates--start badge--dates__start\">\n                                avril 16, 2024                            <\/span>\n                                                                                                        <\/div>\n                                                                            <\/div>\n                \t\t<\/div>\n\t\t<div class=\"content-item__content-footer\">\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t<\/div>\n\n    <\/article>\n\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t<\/div>\n<\/nav>\n\n\n\n<h5 class=\"wp-block-heading has-border-color has-has-red-border-color-border-color  mhh-mcn-v1-heading mhh-mcn-v1-heading--ddeef088cedca953cd8fb112dea2709a\"><strong>R\u00e9f\u00e9rences:<\/strong><\/h5>\n\n\n\n<ol class=\"mhh-mcn-v2-clist mhh-mcn-v2-clist--e4cb53bd88c8a4373ef6af79f784fc3a mhh-mcn-list mhh-mcn-v2-clist--ordered mhh-mcn-v2-clist--ordered-decimal\" dir=\"ltr\" lang=\"fr-FR\" start=\"1\">\n    \n<li class=\"mhh-mcn-list-item mhh-mcn-v2-list-item\">\n    Office f\u00e9d\u00e9ral de la sant\u00e9 publique, Liste des sp\u00e9cialit\u00e9s, www.spezialitaetenliste.ch, \u00e9tat au 1er novembre 2021.    <\/li>\n\n\n<li class=\"mhh-mcn-list-item mhh-mcn-v2-list-item\">\n    Information professionnelle KEYTRUDA\u00ae (pembrolizumab), www.swissmedicinfo.ch.    <\/li>\n\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Patient atteint d\u2019un NSCLC PD-L1 n\u00e9gatif: quel traitement est judicieux? Octobre 2020Un architecte \u00e2g\u00e9 de 60 ans, en retraite anticip\u00e9e, [&hellip;]<\/p>\n","protected":false},"author":427,"featured_media":47860,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mhh_sticky_footer_settings":{"entityId":0},"_mhh_sticky_footer_posts":"","_mhh_sticky_footer_expanded":false,"_mhh_mcn_text_direction":"","_mhh_mcn_language":"","_mhh_mcn_left_sidebar_settings":{"entityId":0},"_mhh_mcn_sidebar_settings":{"entityId":0},"mhh_mcn_side_navigation_style":{"fontSize":{"l":"","m":"","s":""},"lineHeight":{"l":1.5,"m":1.5,"s":1.5},"itemColor":"","hoverItemColor":"","currentItemColor":"","borderItemColor":"","backgroundItemHoverColor":"","themeColor":""},"_mhh_mcn_child_page_navigation":{"isActive":false,"isSticky":false},"hide_header":false,"show_top_bar":false,"hide_footer":false,"full_width_layout":false,"icon":null,"job_code":"","hide_featured_image":true,"primary_tag":840,"editor_notices":[],"mconnectHideShareThis":false,"footnotes":"","sidebar_toogle":0,"sidebar_toogle_notification_warning":true,"sidebar_toogle_notification_alert":true,"content_expiration_sidebar_date":"","content_expiration_sidebar_expired_post_status":"","content_expiration_sidebar_redirection":""},"categories":[792],"tags":[840],"ga4_page_audience":[],"ga4_page_birn_id":[],"ga4_page_branding":[959],"ga4_page_businessunit":[963],"ga4_page_campaign":[],"ga4_page_content_purpose":[],"ga4_page_customer_journey_stage":[],"ga4_page_customer_specialty":[],"ga4_page_experience":[],"ga4_page_indication":[],"ga4_page_material_intent":[1207],"ga4_page_product":[],"ga4_page_region":[],"ga4_page_therapeuticarea":[],"tx-therapeutic-area":[627],"tx-product":[],"tx-pathology":[803],"tx-content-type":[],"tx-active-ingredient":[],"access":[],"user_status":[],"user_role":[],"class_list":["post-55771","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-onco-news","tag-cancer-du-poumon"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Patient atteint d\u2019un NSCLC PD-L1 n\u00e9gatif: quel traitement est judicieux? - MyMSD.ch FR Onco News<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/pd-l1-neg-nsclc-patient-quel-traitemant-est-judicieux\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Patient atteint d\u2019un NSCLC PD-L1 n\u00e9gatif: quel traitement est judicieux? - MyMSD.ch FR Onco News\" \/>\n<meta property=\"og:description\" content=\"Patient atteint d\u2019un NSCLC PD-L1 n\u00e9gatif: quel traitement est judicieux? Octobre 2020Un architecte \u00e2g\u00e9 de 60 ans, en retraite anticip\u00e9e, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/pd-l1-neg-nsclc-patient-quel-traitemant-est-judicieux\/\" \/>\n<meta property=\"og:site_name\" content=\"MyMSD.ch FR\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-26T11:42:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-23T18:27:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/03\/spot_patients-insight_v2-white_lo_96dpi.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"michaelhuesler1\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"michaelhuesler1\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/pd-l1-neg-nsclc-patient-quel-traitemant-est-judicieux\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/pd-l1-neg-nsclc-patient-quel-traitemant-est-judicieux\/\"},\"author\":{\"name\":\"michaelhuesler1\",\"@id\":\"https:\/\/www.mymsd.ch\/fr\/#\/schema\/person\/0c7449d8e3dcf22b059331a9142e4dde\"},\"headline\":\"Patient atteint d\u2019un NSCLC PD-L1 n\u00e9gatif: quel traitement est judicieux?\",\"datePublished\":\"2022-07-26T11:42:31+00:00\",\"dateModified\":\"2025-11-23T18:27:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/pd-l1-neg-nsclc-patient-quel-traitemant-est-judicieux\/\"},\"wordCount\":138,\"publisher\":{\"@id\":\"https:\/\/www.mymsd.ch\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/pd-l1-neg-nsclc-patient-quel-traitemant-est-judicieux\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/03\/spot_patients-insight_v2-white_lo_96dpi.jpg\",\"keywords\":[\"Cancer du poumon\"],\"articleSection\":[\"Onco News\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/pd-l1-neg-nsclc-patient-quel-traitemant-est-judicieux\/\",\"url\":\"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/pd-l1-neg-nsclc-patient-quel-traitemant-est-judicieux\/\",\"name\":\"Patient atteint d\u2019un NSCLC PD-L1 n\u00e9gatif: quel traitement est judicieux? - MyMSD.ch FR Onco News\",\"isPartOf\":{\"@id\":\"https:\/\/www.mymsd.ch\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/pd-l1-neg-nsclc-patient-quel-traitemant-est-judicieux\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/pd-l1-neg-nsclc-patient-quel-traitemant-est-judicieux\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/03\/spot_patients-insight_v2-white_lo_96dpi.jpg\",\"datePublished\":\"2022-07-26T11:42:31+00:00\",\"dateModified\":\"2025-11-23T18:27:07+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/pd-l1-neg-nsclc-patient-quel-traitemant-est-judicieux\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/pd-l1-neg-nsclc-patient-quel-traitemant-est-judicieux\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/pd-l1-neg-nsclc-patient-quel-traitemant-est-judicieux\/#primaryimage\",\"url\":\"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/03\/spot_patients-insight_v2-white_lo_96dpi.jpg\",\"contentUrl\":\"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/03\/spot_patients-insight_v2-white_lo_96dpi.jpg\",\"width\":1280,\"height\":720,\"caption\":\"Spot patients insight v2 white 96dpi\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/pd-l1-neg-nsclc-patient-quel-traitemant-est-judicieux\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.mymsd.ch\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Patient atteint d\u2019un NSCLC PD-L1 n\u00e9gatif: quel traitement est judicieux?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.mymsd.ch\/fr\/#website\",\"url\":\"https:\/\/www.mymsd.ch\/fr\/\",\"name\":\"MyMSD.ch FR\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.mymsd.ch\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.mymsd.ch\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.mymsd.ch\/fr\/#organization\",\"name\":\"MSD Switzerland\",\"url\":\"https:\/\/www.mymsd.ch\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.mymsd.ch\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2023\/10\/cropped-myMSD-logo.png\",\"contentUrl\":\"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2023\/10\/cropped-myMSD-logo.png\",\"width\":4084,\"height\":692,\"caption\":\"MSD Switzerland\"},\"image\":{\"@id\":\"https:\/\/www.mymsd.ch\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.mymsd.ch\/fr\/#\/schema\/person\/0c7449d8e3dcf22b059331a9142e4dde\",\"name\":\"michaelhuesler1\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.mymsd.ch\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a15aa52280d3c01526e7127aad7982d2c54f068dc5b17b406fb10311b6eff8ed?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a15aa52280d3c01526e7127aad7982d2c54f068dc5b17b406fb10311b6eff8ed?s=96&d=mm&r=g\",\"caption\":\"michaelhuesler1\"},\"url\":\"https:\/\/www.mymsd.ch\/fr\/author\/michaelhuesler1\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Patient atteint d\u2019un NSCLC PD-L1 n\u00e9gatif: quel traitement est judicieux? - MyMSD.ch FR Onco News","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/pd-l1-neg-nsclc-patient-quel-traitemant-est-judicieux\/","og_locale":"fr_FR","og_type":"article","og_title":"Patient atteint d\u2019un NSCLC PD-L1 n\u00e9gatif: quel traitement est judicieux? - MyMSD.ch FR Onco News","og_description":"Patient atteint d\u2019un NSCLC PD-L1 n\u00e9gatif: quel traitement est judicieux? Octobre 2020Un architecte \u00e2g\u00e9 de 60 ans, en retraite anticip\u00e9e, [&hellip;]","og_url":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/pd-l1-neg-nsclc-patient-quel-traitemant-est-judicieux\/","og_site_name":"MyMSD.ch FR","article_published_time":"2022-07-26T11:42:31+00:00","article_modified_time":"2025-11-23T18:27:07+00:00","og_image":[{"width":1280,"height":720,"url":"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/03\/spot_patients-insight_v2-white_lo_96dpi.jpg","type":"image\/jpeg"}],"author":"michaelhuesler1","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"michaelhuesler1","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/pd-l1-neg-nsclc-patient-quel-traitemant-est-judicieux\/#article","isPartOf":{"@id":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/pd-l1-neg-nsclc-patient-quel-traitemant-est-judicieux\/"},"author":{"name":"michaelhuesler1","@id":"https:\/\/www.mymsd.ch\/fr\/#\/schema\/person\/0c7449d8e3dcf22b059331a9142e4dde"},"headline":"Patient atteint d\u2019un NSCLC PD-L1 n\u00e9gatif: quel traitement est judicieux?","datePublished":"2022-07-26T11:42:31+00:00","dateModified":"2025-11-23T18:27:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/pd-l1-neg-nsclc-patient-quel-traitemant-est-judicieux\/"},"wordCount":138,"publisher":{"@id":"https:\/\/www.mymsd.ch\/fr\/#organization"},"image":{"@id":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/pd-l1-neg-nsclc-patient-quel-traitemant-est-judicieux\/#primaryimage"},"thumbnailUrl":"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/03\/spot_patients-insight_v2-white_lo_96dpi.jpg","keywords":["Cancer du poumon"],"articleSection":["Onco News"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/pd-l1-neg-nsclc-patient-quel-traitemant-est-judicieux\/","url":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/pd-l1-neg-nsclc-patient-quel-traitemant-est-judicieux\/","name":"Patient atteint d\u2019un NSCLC PD-L1 n\u00e9gatif: quel traitement est judicieux? - MyMSD.ch FR Onco News","isPartOf":{"@id":"https:\/\/www.mymsd.ch\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/pd-l1-neg-nsclc-patient-quel-traitemant-est-judicieux\/#primaryimage"},"image":{"@id":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/pd-l1-neg-nsclc-patient-quel-traitemant-est-judicieux\/#primaryimage"},"thumbnailUrl":"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/03\/spot_patients-insight_v2-white_lo_96dpi.jpg","datePublished":"2022-07-26T11:42:31+00:00","dateModified":"2025-11-23T18:27:07+00:00","breadcrumb":{"@id":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/pd-l1-neg-nsclc-patient-quel-traitemant-est-judicieux\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/pd-l1-neg-nsclc-patient-quel-traitemant-est-judicieux\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/pd-l1-neg-nsclc-patient-quel-traitemant-est-judicieux\/#primaryimage","url":"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/03\/spot_patients-insight_v2-white_lo_96dpi.jpg","contentUrl":"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/03\/spot_patients-insight_v2-white_lo_96dpi.jpg","width":1280,"height":720,"caption":"Spot patients insight v2 white 96dpi"},{"@type":"BreadcrumbList","@id":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/pd-l1-neg-nsclc-patient-quel-traitemant-est-judicieux\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.mymsd.ch\/fr\/"},{"@type":"ListItem","position":2,"name":"Patient atteint d\u2019un NSCLC PD-L1 n\u00e9gatif: quel traitement est judicieux?"}]},{"@type":"WebSite","@id":"https:\/\/www.mymsd.ch\/fr\/#website","url":"https:\/\/www.mymsd.ch\/fr\/","name":"MyMSD.ch FR","description":"","publisher":{"@id":"https:\/\/www.mymsd.ch\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.mymsd.ch\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.mymsd.ch\/fr\/#organization","name":"MSD Switzerland","url":"https:\/\/www.mymsd.ch\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.mymsd.ch\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2023\/10\/cropped-myMSD-logo.png","contentUrl":"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2023\/10\/cropped-myMSD-logo.png","width":4084,"height":692,"caption":"MSD Switzerland"},"image":{"@id":"https:\/\/www.mymsd.ch\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.mymsd.ch\/fr\/#\/schema\/person\/0c7449d8e3dcf22b059331a9142e4dde","name":"michaelhuesler1","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.mymsd.ch\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/a15aa52280d3c01526e7127aad7982d2c54f068dc5b17b406fb10311b6eff8ed?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a15aa52280d3c01526e7127aad7982d2c54f068dc5b17b406fb10311b6eff8ed?s=96&d=mm&r=g","caption":"michaelhuesler1"},"url":"https:\/\/www.mymsd.ch\/fr\/author\/michaelhuesler1\/"}]}},"_links":{"self":[{"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/posts\/55771","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/users\/427"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/comments?post=55771"}],"version-history":[{"count":15,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/posts\/55771\/revisions"}],"predecessor-version":[{"id":102530,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/posts\/55771\/revisions\/102530"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/media\/47860"}],"wp:attachment":[{"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/media?parent=55771"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/categories?post=55771"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/tags?post=55771"},{"taxonomy":"ga4_page_audience","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_audience?post=55771"},{"taxonomy":"ga4_page_birn_id","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_birn_id?post=55771"},{"taxonomy":"ga4_page_branding","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_branding?post=55771"},{"taxonomy":"ga4_page_businessunit","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_businessunit?post=55771"},{"taxonomy":"ga4_page_campaign","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_campaign?post=55771"},{"taxonomy":"ga4_page_content_purpose","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_content_purpose?post=55771"},{"taxonomy":"ga4_page_customer_journey_stage","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_customer_journey_stage?post=55771"},{"taxonomy":"ga4_page_customer_specialty","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_customer_specialty?post=55771"},{"taxonomy":"ga4_page_experience","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_experience?post=55771"},{"taxonomy":"ga4_page_indication","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_indication?post=55771"},{"taxonomy":"ga4_page_material_intent","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_material_intent?post=55771"},{"taxonomy":"ga4_page_product","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_product?post=55771"},{"taxonomy":"ga4_page_region","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_region?post=55771"},{"taxonomy":"ga4_page_therapeuticarea","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_therapeuticarea?post=55771"},{"taxonomy":"tx-therapeutic-area","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/tx-therapeutic-area?post=55771"},{"taxonomy":"tx-product","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/tx-product?post=55771"},{"taxonomy":"tx-pathology","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/tx-pathology?post=55771"},{"taxonomy":"tx-content-type","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/tx-content-type?post=55771"},{"taxonomy":"tx-active-ingredient","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/tx-active-ingredient?post=55771"},{"taxonomy":"access","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/access?post=55771"},{"taxonomy":"user_status","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/user_status?post=55771"},{"taxonomy":"user_role","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/user_role?post=55771"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}